The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...

The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to ...

Leukocyte count linked to severity of post-acute sequelae of SARS-CoV-2 infection, but not of PASC occurrence or related cognitive outcomes ...

HealthDay News — A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful CIPN (40.44% and 38.35%, respectively). HealthDay News — The pooled prevalence of chronic ...

Secretary of State Marco Rubio announced the waiver on Tuesday; however, exactly what it covers remains unclear. While the waiver does allow for the resumption of distributing HIV medications, the ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.

Study participants cite historical exploitation, rapid vaccine development, and coercive messaging as primary reasons for COVID-19 vaccine hesitancy. Complex and deeply rooted factors, including ...

Source: Getty Images News of restrictions placed on federal health agencies has been met with public outcry and prompted the ...